Emcure Pharmaceuticals Cash Flow Annual

BSE: 544210 | NSE: EMCURE | ISIN: INE168P01015 | Sector: -
1,297.15 +13.60 (1.06%)Updated : 11 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -1,464.51119.0077.5265.92
Net Changein Cash -58.30218.52133.6441.87
Cash Taxes Paid 246.86223.65200.48311.18
Net Income/ Starting Line 971.35727.23747.21972.55
Changesin Working Capital -671.16-173.14-492.71-388.96
Cashfrom Operating Activities 851.701,097.24746.85982.33
Cash Interest Paid 128.68208.18178.56155.32
Cashfrom Financing Activities -813.96-164.21-145.40-151.85
Issuance( Retirement)of Stock Net 779.23-12.58--
Depreciation/ Depletion 384.13312.41260.12244.86
Other Investing Cash Flow Items Total 312.93-405.38-64.32-391.80
Capital Expenditures -406.93-307.13-403.36-396.99
period Type ----
Foreign Exchange Effects -2.05-2.00-0.130.19
Non- Cash Items 167.38230.74232.23153.89
Financing Cash Flow Items -128.68-270.63-222.92-217.77
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -94.00-712.51-467.69-788.79
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,520.10+111.05(4.61%)
1,173.75+9.25(0.79%)
858.70+6.05(0.71%)
3,074.95-86.80 (-2.75%)